Nervous Disorder TRIZ Cases

A human artificial chromosome vector carries centromere and telomere sequences to deliver therapeutic genes into mammalian cells.

Antibodies 11E8 and h37E1B5 bind integrin alpha-v beta-8 to block active TGF-beta release without disrupting cell adhesion functions.

Topical dronabinol administration improves cognitive function and reduces chemo brain symptoms without adverse effects.

Fusion antibody mediates transferrin receptor transport of alpha-L-iduronidase across the blood-brain barrier, resolving systemic delivery limitations.

A 4-substituted catechol compound suppresses tau protein aggregation in cells.

Monoclonal antibody targets amyloid beta aggregates with high conformational specificity through targeted complementarity determining regions.

Combining cannabidiol with tetrahydrocannabivarin reduces seizure frequency in animal models.

Culturing motor neuron progenitor cells with olfactory ensheathing cells to sustain self-replication and differentiation into mature neurons.

A modified nicotine dehydrogenase mutant accelerates product release through targeted amino acid substitutions in the enzyme's active channel.

Specific butyrylcholinesterase inhibitors reduce enzyme activity, preventing beta-amyloid plaque formation while avoiding adverse peripheral effects.

Homotaurine supplements delay cognitive decline onset by providing neuroprotection and preserving memory function in aging dogs.

C60 fullerene derivatives target NFkB, IL-6, and NADPH oxidase pathways to treat schizophrenia, psychosis, and dementias by reducing inflammation.

High bisdemethoxycurcumin curcuminoid compositions overcome poor bioavailability and chemical instability of conventional turmeric extracts.

A solvent extract of Peucedanum japonicum Thunb. activates sirtuin-1 gene expression, suppressing cell senescence caused by oxidative stress.

Formula I compounds inhibit autotaxin activity and modulate lysophosphatidic acid levels to address inadequate inhibition in existing treatments.

Carpipramine mediates dopaminergic pathways to reduce depressive behaviors and anxiety, addressing treatment resistance where standard antidepressants fail.

Segmented K1K1 proteins bypass heparan sulfate immobilization to enhance tissue diffusion and lower production costs.

A composition of aldehyde functional monoterpenoids and zinc targets respiratory symptoms through inhalation delivery.

Convection-enhanced infusion bypasses the blood-brain barrier to deliver GDNF directly to the putamen, restoring dopamine stores and improving motor function.

Biased ligands modulate G-protein signaling to provide analgesia while minimizing respiratory depression and gastrointestinal side effects.

Hairpin structured shRNA vectors deliver allele-selective silencing of mutant genes containing CAG repeats while sparing normal proteins.

TZIP peptides bind Tat-TAR complexes to inhibit HIV transcription while sparing healthy cells from damage.

Administering colony stimulating factors to stimulate hematopoietic cell proliferation and modulate immune responses in demyelinating diseases.

Anhydrous hydrogel eliminates water content to enable stable cannabinoid delivery in moisture-sensitive oral applications.

A catalytic process converts halogenated pyridines to Grignard reagents at moderate temperatures for efficient intermediate synthesis.

Antibodies targeting prefibrillar oligomers via stabilized peptides reduce adverse effects from non-toxic amyloid forms.

ANG-2 inhibitors block TIE2 interactions to reduce monocyte migration into the CNS, mitigating persistent inflammation and tissue damage in multiple sclerosis.

Antibodies bind specific alpha-synuclein epitopes to induce an immunogenic response that clears pathological protein deposits.

Bri2 acts as a molecular chaperone to block amyloid plaque buildup in Alzheimer's disease.

Carboxyl-free polyacrylate adhesive dissolves fentanyl to prevent excessive absorption during leaks, ensuring safety against fatal overdoses.

A method creates hypo-metallated metallothionein proteins with defined redox states and specific cysteine sulfhydryl group configurations.

Integrates sulindac with other compounds to address hyperactivity and memory loss in fragile X syndrome.

Optimized molecular structures balance potency with pharmacokinetic properties to overcome poor delivery of current agonists to target organs.

Carbamoyl phenylalaninol analogs mimic biological activity to treat narcolepsy while reducing side effects.

Ex-vivo differentiated astrocytes support motor neuron survival by creating a neuroprotective environment that delays disease progression.

Enantiomerically pure 9CDHRA synthesis overcomes low endogenous ligand concentrations to enable effective RXR activation.

Converting hydromorphone into aryl carboxylic acid prodrugs prevents direct receptor interaction, reducing abuse potential and opioid-induced constipation.

An L-shaped guide tube and catheter deliver nucleic acid molecules into the subpial space to bypass the pial membrane.

Novel gamma-hydroxybutyric acid prodrugs modify molecular structures to enhance oral bioavailability and therapeutic stability.

Optimized dsRNA complementary regions under 30 nucleotides resolve the trade-off between binding specificity and IC50 values for effective GSK-3 inhibition.

Combining idalopirdine with acetylcholinesterase inhibitors improves gait stability in Parkinson's disease patients.

18-Methoxycoronaridine salt acts as a negative allosteric modulator of alpha3beta4 nicotinic cholinergic receptors to reduce drug self-administration.

Antioxidant stabilizers protect donepezil adhesive preparations from environmental oxidation, maintaining appearance stability over time.

Liver hydrolysate with low lipid content inhibits cognitive decline, avoiding adverse gastrointestinal effects common in conventional dementia treatments.

A bifunctional fusion antibody transports enzymes across the blood-brain barrier via receptor-mediated transcytosis.

PrPc antagonists inhibit synaptic dysfunction by blocking amyloid-beta oligomer binding, resolving receptor specificity gaps.

Segmented antibody fragments target amyloid beta oligomers to overcome monomer interference in cerebrospinal fluid.